19
staff
Paul Irving
Paul Irving is a corporate and nonprofit director and senior advisor to leaders in business, inve
stment, philanthropy, and academia.
+ Read More
panel
Diabetes and Obesity: An Urgent Global Health Crisis
Despite many treatments and technological advances, the health of the US and global populations
continues to decline. Chronic disease continues to increase and have a detrimental effect on personal health and health-care costs.
+ Read More
panel
Housing Finance Reform: Will We Finally Get the Stone Up the Hill?
After a decade of debate, the post-crisis US housing finance system seems poised for major refor
m. What needs to change and why? Who has the power to decide and act? Will change be incremental or far-reaching and what will drive the answer?
+ Read More
panel
Stand in Your Power: The Mindful Way
Mindfulness practices are proliferating across a range of fields and institutions, both domestic
ally and globally.
+ Read More
panel
Pain Points and Potential for Cell and Gene Therapies
Cell and gene therapies have the potential to transform the lives of patients and their families
. As judged by patients' perspectives and experiences, how close are we to realizing this potential?
+ Read More
panel
Brain Health: Turning Scientific Discovery into Action (Invite only)
The brain is the most important organ in the body, generating every thought, sensation, memory,
emotion, and movement. Yet we rarely focus specifically on caring for the brain and generally do not monitor changes in brain health and function over time.
+ Read More
panel
Achieving More Person-Centered Prevention and Treatment of Chronic Diseases
Life expectancy in the US declined by 1.5 years from 2019 to 2020 in the largest 1-year drop sin
ce World War II. While COVID-19 caused 74 percent of the decline, chronic conditions such as diabetes, heart disease, and kidney disease take a heavy toll.
+ Read More
panel
Is Digital Health a Bridge to Health Equity and Representation?
Systemic health-care inequities exposed by the COVID-19 pandemic included minority under-represe
ntation in research and disparities in care.
+ Read More
panel
The Silent Patient at Work: How Employers Are Doing More for Substance Use Disorders and Mental Health
The CDC reported a record 93,000 overdose deaths in the US in 2020. Though addiction may yield t
o COVID-19 in the news, this grim number tells that the addiction crisis rages on, exacerbated by the effects of necessary social distancing measures.
+ Read More
video
Housing Finance Reform: Will We Finally Get the Stone Up the Hill?
After a decade of debate, the post-crisis US housing finance system seems poised for major reform.
What needs to change and why? Who has the power to decide and act? Will change be incremental or far-reaching and what will drive the answer?
+ Read More
video
Dec. 7 at 11:30 am ET | Pain Points and Potential for Cell and Gene Therapies
Cell and gene therapies have the potential to transform the lives of patients and their families.
As judged by patients' perspectives and experiences, how close are we to realizing this potential?
+ Read More
video
Dec. 7 at 1:00 pm ET | Achieving More Person-Centered Prevention and Treatment of Chronic Diseases
Life expectancy in the US declined by 1.5 years from 2019 to 2020 in the largest 1-year drop since
World War II. While COVID-19 caused 74 percent of the decline, chronic conditions such as diabetes, heart disease, and kidney disease take a heavy toll.
+ Read More